Press Releases Press Releases Year None20222021202020192018201720162015 May 13, 2022 InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update May 05, 2022 InMed to Supply Rare Cannabinoids to Radicle Science’s “Radicle Energy Study” to Assess the Health Effects of THCV Apr 28, 2022 InMed Expands Patent Portfolio with Novel Cannabinoid Analogs and Advances Collaboration Agreement with Leading Cannabinoid Research Expert Apr 21, 2022 InMed Commercializes Cannabidivarin (CBDV), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector Apr 19, 2022 InMed to Participate in Upcoming Investor Conferences in April and May 2022 Mar 17, 2022 InMed Announces Management Changes Mar 08, 2022 InMed to Present at the 34th Annual Roth Conference Feb 15, 2022 InMed Pharmaceuticals Strengthens its Commercial Leadership Team with the Appointment of Vice President of Sales and Marketing for BayMedica Feb 14, 2022 InMed Pharmaceuticals Reports Second Quarter Fiscal 2022 Financial Results and Provides Business Update Feb 10, 2022 InMed Pharmaceuticals to Report Second Quarter Fiscal 2022 Financial Results and Business Update on February 15, 2022 Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page › Last page » Displaying 1 - 10 of 203 Investor Alerts Sign up for investor alerts! Sign Up Information Request Send us a request for information Learn More
Press Releases Year None20222021202020192018201720162015 May 13, 2022 InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update May 05, 2022 InMed to Supply Rare Cannabinoids to Radicle Science’s “Radicle Energy Study” to Assess the Health Effects of THCV Apr 28, 2022 InMed Expands Patent Portfolio with Novel Cannabinoid Analogs and Advances Collaboration Agreement with Leading Cannabinoid Research Expert Apr 21, 2022 InMed Commercializes Cannabidivarin (CBDV), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector Apr 19, 2022 InMed to Participate in Upcoming Investor Conferences in April and May 2022 Mar 17, 2022 InMed Announces Management Changes Mar 08, 2022 InMed to Present at the 34th Annual Roth Conference Feb 15, 2022 InMed Pharmaceuticals Strengthens its Commercial Leadership Team with the Appointment of Vice President of Sales and Marketing for BayMedica Feb 14, 2022 InMed Pharmaceuticals Reports Second Quarter Fiscal 2022 Financial Results and Provides Business Update Feb 10, 2022 InMed Pharmaceuticals to Report Second Quarter Fiscal 2022 Financial Results and Business Update on February 15, 2022 Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page › Last page » Displaying 1 - 10 of 203